Literature DB >> 12675688

Segregation analysis of prostate cancer in France: evidence for autosomal dominant inheritance and residual brother-brother dependence.

A Valeri1, L Briollais, R Azzouzi, G Fournier, P Mangin, P Berthon, O Cussenot, F Demenais.   

Abstract

Four segregation analyses concerning prostate cancer (CaP), three conducted in the United States and one in Northern Europe, have shown evidence for a dominant major gene but with different parameter estimates. A recent segregation analysis of Australian pedigrees has found a better fit of a two-locus model than single-locus models. This model included a dominantly inherited increased risk that was greater at younger ages and a recessively inherited or X-linked increased risk that was greater at older ages. Recent linkage analyses have led to the detection of at least 8 CaP predisposing genes, suggesting a complex inheritance and genetic heterogeneity. To assess the nature of familial aggregation of prostate cancer in France, segregation analysis was conducted in 691 families ascertained through 691 CaP patients, recruited from three French hospitals and unselected with respect to age at diagnosis, clinical stage or family history. This mode of family inclusion, without any particular selection of the probands, is unique, as probands from all previous analyses were selected according to various criteria. Segregation analysis was carried out using the logistic hazard regressive model, as incorporated in the REGRESS program, which can accommodate a major gene effect, residual familial dependences of any origin (genetic and/or environmental), and covariates, while including survival analysis concepts. Segregation analysis showed evidence for the segregation of an autosomal dominant gene (allele frequency of 0.03%) with an additional brother-brother dependence. The estimated cumulative risks of prostate cancer by age 85 years, among subjects with the at-risk genotype, were 86% in the fathers' generation and 99% in the probands' generation. This study supports the model of Mendelian transmission of a rare autosomal dominant gene with high penetrance, and demonstrates that additional genetic and/or common sibling environmental factors are involved to account for the familial clustering of CaP.

Entities:  

Mesh:

Year:  2003        PMID: 12675688     DOI: 10.1046/j.1469-1809.2003.00022.x

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  8 in total

1.  Genomewide linkage analysis of familial prostate cancer in the Japanese population.

Authors:  Hiroshi Matsui; Kazuhiro Suzuki; Nobuaki Ohtake; Seiji Nakata; Toshiyuki Takeuchi; Hidetoshi Yamanaka; Ituro Inoue
Journal:  J Hum Genet       Date:  2003-12-10       Impact factor: 3.172

2.  Segregation analysis of 1,546 prostate cancer families in Finland shows recessive inheritance.

Authors:  Sanna Pakkanen; Agnes B Baffoe-Bonnie; Mika P Matikainen; Pasi A Koivisto; Teuvo L J Tammela; Snehal Deshmukh; Liang Ou; Joan E Bailey-Wilson; Johanna Schleutker
Journal:  Hum Genet       Date:  2007-01-03       Impact factor: 4.132

3.  Global prostate cancer incidence and the migration, settlement, and admixture history of the Northern Europeans.

Authors:  Kristin Gunderson; Christopher Y Wang; Ruoxiang Wang
Journal:  Cancer Epidemiol       Date:  2010-12-16       Impact factor: 2.984

4.  Chromosome 8q24 variants are associated with prostate cancer risk in a high risk population of African ancestry.

Authors:  Michael N Okobia; Joseph M Zmuda; Robert E Ferrell; Alan L Patrick; Clareann H Bunker
Journal:  Prostate       Date:  2011-01-12       Impact factor: 4.104

5.  Fine mapping of familial prostate cancer families narrows the interval for a susceptibility locus on chromosome 22q12.3 to 1.36 Mb.

Authors:  Bo Johanneson; Shannon K McDonnell; Danielle M Karyadi; Scott J Hebbring; Liang Wang; Kerry Deutsch; Laura McIntosh; Erika M Kwon; Miia Suuriniemi; Janet L Stanford; Daniel J Schaid; Elaine A Ostrander; Stephen N Thibodeau
Journal:  Hum Genet       Date:  2007-12-08       Impact factor: 4.132

6.  Prostate cancer risk-associated genetic markers and their potential clinical utility.

Authors:  Jianfeng Xu; Jielin Sun; S Lilly Zheng
Journal:  Asian J Androl       Date:  2013-04-08       Impact factor: 3.285

7.  Association of a single-nucleotide polymorphism from chromosome 17q12 with the aggressiveness of prostate cancer in a Hispanic population.

Authors:  Pablo A Rojas; Verónica Torres-Estay; Javier Cerda-Infante; Viviana P Montecinos; Javier Domínguez; José Arenas; Alejandro S Godoy; Ignacio F San Francisco
Journal:  J Cancer Res Clin Oncol       Date:  2014-03-14       Impact factor: 4.553

8.  Fine mapping the KLK3 locus on chromosome 19q13.33 associated with prostate cancer susceptibility and PSA levels.

Authors:  Hemang Parikh; Zhaoming Wang; Kerry A Pettigrew; Jinping Jia; Sarah Daugherty; Meredith Yeager; Kevin B Jacobs; Amy Hutchinson; Laura Burdett; Michael Cullen; Liqun Qi; Joseph Boland; Irene Collins; Thomas J Albert; Lars J Vatten; Kristian Hveem; Inger Njølstad; Geraldine Cancel-Tassin; Olivier Cussenot; Antoine Valeri; Jarmo Virtamo; Michael J Thun; Heather Spencer Feigelson; W Ryan Diver; Nilanjan Chatterjee; Gilles Thomas; Demetrius Albanes; Stephen J Chanock; David J Hunter; Robert Hoover; Richard B Hayes; Sonja I Berndt; Joshua Sampson; Laufey Amundadottir
Journal:  Hum Genet       Date:  2011-02-15       Impact factor: 4.132

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.